Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burston

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
ACS Chemical Neuroscience|June 5, 2013
Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitorsMicah J Niphakis, Armand B Cognetta, Jae Won Chang, et al.
Stem Cells International|February 14, 2018
Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of OsteoarthritisVictoria Chapman, Hareklea Markides, Devi Rani Sagar, et al.
Molecular Pain|November 19, 2011
The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic painDevi Rani Sagar, James J Burston, Gareth J Hathway, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis PainJunting Huang, James J Burston, Li Li, et al.
Scientific Reports|March 20, 2019
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritisSadaf Ashraf, Masar Radhi, Peter Gowler, et al.
Neuroimage|June 22, 2017
Manganese-enhanced magnetic resonance imaging depicts brain activity in models of acute and chronic pain: A new window to study experimental spontaneous pain?I M Devonshire, J J Burston, L Xu, et al.
Pain Reports|February 2, 2019
Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis painLilian N Nwosu, Peter R W Gowler, James J Burston, et al.
Osteoarthritis and Cartilage|May 22, 2016
The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis painL Xu, L N Nwosu, J J Burston, et al.
British Journal of Pharmacology|July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseL Thors, J J Burston, B J Alter, et al.
Pain Reports|February 7, 2022
Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesiaAmanda Lillywhite, Stephen G Woodhams, Sara V Gonçalves, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
ACS Chemical Neuroscience|June 5, 2013
Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitorsMicah J Niphakis, Armand B Cognetta, Jae Won Chang, et al.
Stem Cells International|February 14, 2018
Therapeutic Benefit for Late, but Not Early, Passage Mesenchymal Stem Cells on Pain Behaviour in an Animal Model of OsteoarthritisVictoria Chapman, Hareklea Markides, Devi Rani Sagar, et al.
Molecular Pain|November 19, 2011
The contribution of spinal glial cells to chronic pain behaviour in the monosodium iodoacetate model of osteoarthritic painDevi Rani Sagar, James J Burston, Gareth J Hathway, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Targeting the D Series Resolvin Receptor System for the Treatment of Osteoarthritis PainJunting Huang, James J Burston, Li Li, et al.
Scientific Reports|March 20, 2019
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritisSadaf Ashraf, Masar Radhi, Peter Gowler, et al.
Neuroimage|June 22, 2017
Manganese-enhanced magnetic resonance imaging depicts brain activity in models of acute and chronic pain: A new window to study experimental spontaneous pain?I M Devonshire, J J Burston, L Xu, et al.
Pain Reports|February 2, 2019
Analgesic effects of the cathepsin K inhibitor L-006235 in the monosodium iodoacetate model of osteoarthritis painLilian N Nwosu, Peter R W Gowler, James J Burston, et al.
Osteoarthritis and Cartilage|May 22, 2016
The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis painL Xu, L N Nwosu, J J Burston, et al.
British Journal of Pharmacology|July 2, 2010
Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseL Thors, J J Burston, B J Alter, et al.
Pain Reports|February 7, 2022
Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesiaAmanda Lillywhite, Stephen G Woodhams, Sara V Gonçalves, et al.
Pageof 7